COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    ketamine | Rett Syndrome
Previous Study | Return to List | Next Study

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03633058
Recruitment Status : Recruiting
First Posted : August 16, 2018
Last Update Posted : October 5, 2020
Vanderbilt University Medical Center
Information provided by (Responsible Party):
Rett Syndrome Research Trust

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : August 2021